Related references
Note: Only part of the references are listed.Asymmetric dimethylarginine, arginine and homoarginine at 11-13 weeks' gestation and preeclampsia: a case-control study
A. A. Khalil et al.
JOURNAL OF HUMAN HYPERTENSION (2013)
Methoxistasis: Integrating the Roles of Homocysteine and Folic Acid in Cardiovascular Pathobiology
Jacob Joseph et al.
NUTRIENTS (2013)
Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of pre-eclampsia: a systematic review and meta-analysis
C. E. Kleinrouweler et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2012)
The Promise of Angiogenic Markers for the Early Diagnosis and Prediction of Preeclampsia
Henning Hagmann et al.
CLINICAL CHEMISTRY (2012)
Candidate biochemical markers for screening of pre-eclampsia in early pregnancy
Jean-Claude Forest et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2012)
Changes in circulating concentrations of soluble fms-like tyrosine kinase-1 and placental growth factor measured by automated electrochemiluminescence immunoassays methods are predictors of preeclampsia
Alfredo Leanos-Miranda et al.
JOURNAL OF HYPERTENSION (2012)
First-Trimester Prediction of Preeclampsia in Nulliparous Women at Low Risk
Leslie Myatt et al.
OBSTETRICS AND GYNECOLOGY (2012)
Methionine metabolism in human pregnancy
Jaividhya Dasarathy et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2010)
Elevated asymmetric dimethylarginine concentrations precede clinical preeclampsia, but not pregnancies with small-for-gestational-age infants
Paul D. Speer et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2008)
Determination of asymmetric dimethylarginine in biological fluids: a paradigm for a successful analytical story
Dimitrios Tsikas
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2008)
Mapping the theories of preeclampsia and the role of angiogenic factors - A systematic review
Mariana Widmer et al.
OBSTETRICS AND GYNECOLOGY (2007)
Soluble endoglin and other circulating antiangiogenic factors in preeclampsia
Richard J. Levine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Concentrations of homocysteine, related metabolites and asymmetric dimethylarginine in preeclamptic women with poor nutritional status
W Herrmann et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2005)
Homocysteine plasma concentration levels for the prediction of preeclampsia in women with chronic hypertension
GG Zeeman et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2003)
Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia
MD Savvidou et al.
LANCET (2003)
Hyperhomocysteinemia, endothelial dysfunction, and cardiovascular risk: the potential role of ADMA
SR Lentz et al.
ATHEROSCLEROSIS SUPPLEMENTS (2003)
Share Paper
